Chosa Oncology ABXSAT:CHOSA 31 FCF Yield % is -5.95 as of Jun. 29, 2026. GuruFocus rates XSAT:CHOSA with a GF Score™ of 31/100. Among 1,415 Biotechnology companies, Chosa Oncology AB ranks better than 59.51% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Chosa Oncology AB FCF Yield % Related Terms
Chosa Oncology AB FCF Yield % Historical Data
* Premium members only.
The historical data trend for Chosa Oncology AB's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSAT:CHOSA vs VRTX, REGN, ALNY: FCF Yield % Comparison
For the Biotechnology subindustry, Chosa Oncology AB's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chosa Oncology AB FCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Chosa Oncology AB's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Chosa Oncology AB's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chosa Oncology AB (XSAT:CHOSA) has a FCF Yield % of -5.95 as of Jun. 29, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Chosa Oncology AB and its competitors. According to the industry distribution chart, Chosa Oncology AB ranks #573 out of 1415 companies in the Biotechnology industry, placing it in the top 40.5%.
Is Chosa Oncology AB's FCF Yield % too high?
Chosa Oncology AB's current FCF Yield % is -5.95. Based on the distribution chart, Chosa Oncology AB ranks #573 out of 1415 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Chosa Oncology AB has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Chosa Oncology AB's FCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Chosa Oncology AB ranks #573 out of 1415 companies for FCF Yield %. This puts Chosa Oncology AB in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Chosa Oncology AB and its competitors. Chosa Oncology AB's current FCF Yield % is -5.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chosa Oncology AB stock overvalued right now?
Chosa Oncology AB (XSAT:CHOSA) has a current FCF Yield % of -5.95. The current FCF Yield % is -5.95. Chosa Oncology AB's overall GF Score™ is 31/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Chosa Oncology AB (XSAT:CHOSA), the current FCF Yield % is -5.95 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSAT:CHOSA has been successfully added to your 
